openPR Logo
Press release

Global Peptide Based Cardiovascular Therapeutics Market : Bivalirudin Sales to Generate US$ 1,360 Mn Revenue by 2022

04-08-2021 05:54 AM CET | Health & Medicine

Press release from: Fact.MR

Therapeutic peptides are used to treat various types of cardiovascular diseases. Initially, the development of peptides as therapeutic agents was avoided by the pharmaceutical industry due to their low stability, rate of degradation and poor delivery. However, in the present times, with increasing amounts of economic resources being diverted to healthcare R&D, new avenues have opened up for peptide therapeutics. Increasing healthcare expenditure and increasing FDI in emerging economies along with the emergence of prominent pharmaceutical and biotech companies is fuelling market growth in peptide therapeutics.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=191

Besides, growing number of people suffering from cardiovascular diseases is also fuelling the market for peptide therapeutics. Breakthroughs in the development of therapeutic peptides for treating cardiovascular diseases and the development of new peptides is also fuelling the market growth. However, various factors such as increasing cost of developing peptides, rapid metabolism of peptide drugs and a stringent regulatory framework may restrain the growth of therapeutic peptides.
The global peptide based cardiovascular therapeutics market is slated to touch a value of nearly US$ 1,960 Mn in the year 2022 and grow at a robust CAGR during the assessment period.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=191

4 Forecast Highlights on Global Peptide Based Cardiovascular Therapeutics Market

1. As per the forecast of Fact.MR, the eptifibatide segment is slated to touch a value of nearly US$ 600 Mn in the year 2022. This represents a robust CAGR growth during the assessment period of 2017-2022. The eptifibatide segment is estimated to account for nearly one-third of the revenue share of the drug segment by the year 2017 end and is expected to gain in market share by the year 2022 end.
2. As per the forecast of Fact.MR, the retail pharmacies segment will reach a value of nearly US$ 425 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The retail pharmacies segment is estimated to account for more than one-third of the revenue share of the distribution channel segment in the year 2017 end and is expected to gain market share by the end of the year 2022.
3. As per the forecast of Fact.MR, North America peptide based cardiovascular therapeutics market is expected to register a robust CAGR over the forecast period and to be valued at nearly US$ 830 Mn by 2022 end.
4. As perFact.MR forecasts, US peptide based cardiovascular therapeutics market is estimated to account for 88.6% revenue share of the global peptide based cardiovascular therapeutics market by 2017 end and is expected to gain market share by 2022 over 2017

For in-depth competitive analysis, buy now - https://www.factmr.com/checkout/191/S

The report has also profiled leading players in the global market for peptide based cardiovascular therapeutics, which will remain active through 2022. These include companies such as Amneal Pharmaceuticals LLC, Fresenius Kabi USA, LLC, Corden Pharma GmbH, AstraZeneca, plc, Novetide Ltd, Pfizer Inc, Dr. Reddy's Laboratories Limited, Ipsen S.A, Apotex Holdings, Inc. and Merck & Co.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/191/peptide-based-cardiovascular-therapeutics-market
Content Source: https://www.factmr.com/media-release/181/peptide-based-cardiovascular-therapeutics-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Peptide Based Cardiovascular Therapeutics Market : Bivalirudin Sales to Generate US$ 1,360 Mn Revenue by 2022 here

News-ID: 2267474 • Views: 129

More Releases from Fact.MR

Increasing use of gallium nitride in military and aerospace industry, fuelled gl …
Gallium nitride is a glass-like substance that is translucent. It can be used with broader bandwidth and tough structure as a semiconductor unit. Compared to the semiconductor form of silicon, it tends to lose less energy. Gallium nitride use is growing with the growth of wireless devices. The gadgets based on gallium nitride have numerous applications, from electronics to telecommunications and automotive. The wider bandwidth means that energy is quickly transferred
Demand for anti-friction coatings is highest in transportation industry. Asia Pa …
Anti-Friction Coatings Market: Overview and Dynamics Anti-Friction coatings are a type of lubricant solution that are similar in formulation to common industrial paints. It comprises of solid lubricants and resins as solvents. The main components of solid lubricants are molybdenum disulphide, Polytetrafluoroethylene (PTFE) and graphite. The most preferred way of applying anti-friction coatings is immersion or by spraying carefully onto the degreased surfaces. There are other methods as well like electrostatic
Automotive Lighting Market to Grow at CAGR of 5 % through 2030 to reach a valuat …
The global automotive lighting market is projected to grow at 5% and will be valued at US$ 65 Bn by the end of the forecast period (2020-2030). However, the COVID-19 crisis has impacted the growth trajectory as the demand for automotives has fallen sharply. In the wake of disruption of supply chains and the shutdown of manufacturing plants, the automotive lighting market growth has been profoundly affected. To get in-depth
Polyamines Market Trends and Analysis (2020-2030): Key Market Dynamics and Growt …
Polyamines market is poised to surpass US$ 200 Mn by 2020 and is set to grow at a steady 4% during the forecast period (2020-2030). Polyamines is a key water treatment chemical and coagulant used for treatment of discharged waste water. Though coagulants constitute a major share of the market, shale inhibitors are growing at a faster rate owing to their high demand in oil & gas well explorations. To get

All 5 Releases


More Releases for CAGR

Catalase Market : Research Observes Strong CAGR Development
The "Global Catalase Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 - 2024", report intends to offer a resourceful means to assess the Catalase Market and entails the all-inclusive analysis and upfront statistics with regards to the market. This new report is committed fulfilling the requirements of the clients by giving them thorough insights into the market. The Catalase Market report, titled Catalase Market, is expansive research
Citicoline Market | CAGR of 14.4%
The global Citicoline Market 2020 Report provides fine intelligence that helps market players to compete well against the tough competition on the basis of growth, sales and other various important factors. The research report lays stress on key growth opportunities and market trends apart from important market dynamics including market drivers and challenges. With the help of this report, involved parties can equip themselves to adapt along with the changes
Footwear Market : Research Observes Strong CAGR Development
The "Global Footwear Market Set for Rapid Growth, to Reach Around USD 320.44 Billion by 2023", report intends to offer a resourceful means to assess the Footwear Market and entails the all-inclusive analysis and upfront statistics with regards to the market. This new report is committed fulfilling the requirements of the clients by giving them thorough insights into the market. The Footwear Market report, titled Footwear Market, is expansive research
Xanthates Market CAGR to Grow at 4.7%
Persistence Market Research in its latest report projects that the global xanthates market will grow at a CAGR of 6.1% over the forecast period (2017-2025). Owing to Xanthates’ excellent mineral ore processing capabilities, its global sales have witnessed a significant rise in recent years. Mining complexity and declining ore quality have led to a major increase in demand for specialty chemicals to process ores. Towards the end of 2025, around
Global Serious Games Market Show 19.2% CAGR
A new report added by Allied Market Research, forecast that the global serious games market was valued at $2,731 million in 2016, and is projected to reach $9,167 million by 2023, growing at a CAGR of 19.2% from 2017 to 2023. The consumers segment is anticipated to grow at the highest rate during the forecast period. Asia-Pacific generated the highest revenue in the global serious games market in 2016 due to
Bioinsecticides market expecting CAGR 5.4%
Reports And Markets Publish a New Market Research Report On –"Bioinsecticides market- Growth, Trends, Forecast for the period (2017 - 2022)" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/1071910-global-bioinsecticides-market-growth-trends-forecast-for-the-period-2017-2022 Pesticides constitute the largest category within the market for crop protection chemicals, with biopesticides accounting for a comparatively minute share. Global consumption of synthetic insecticides is projected to reach 833.32 thousand tons by volume and USD 19.6 billion by value by 2020